Senseonics Holdings, Inc., a medical technology company, develops and markets continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company is headquartered in Germantown, Maryland.
| Revenue (TTM) | $35.26M |
| Gross Profit (TTM) | $15.76M |
| EBITDA | $-66.83M |
| Operating Margin | -146.80% |
| Return on Equity | -168.30% |
| Return on Assets | -37.70% |
| Revenue/Share (TTM) | $0.84 |
| Book Value | $1.48 |
| Price-to-Book | 11.16 |
| Price-to-Sales (TTM) | 10.59 |
| EV/Revenue | 8.89 |
| EV/EBITDA | 1.76 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 71.80% |
| Shares Outstanding | $52.20M |
| Float | $38.52M |
| % Insiders | 12.59% |
| % Institutions | 21.05% |
Volatility is currently contracting